You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Final Cox Proportional Hazards regression model for CMV incidence (with mTOR inhibitor fitted as a time dependent variable)

From: Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience

Variable Adjusted Hazard Ratio (95% CI) p-value
Recipient aged ≥65 at transplant 1.85 (0.96, 3.58) 0.067
Donor aged ≥60 2.24 (1.36, 3.67) 0.001
Deceased donor 2.03 (1.18, 3.50) 0.011
Donor/Recipient CMV status
 D/R+ (reference)
 D+/R 5.44 (2.49, 11.89) <0.001
 D+/R+ 1.73 (0.84, 3.56) 0.138
mTOR inhibitor 0.31 (0.09, 1.02) 0.054